delta9-tetrahydrocannabinol hemisuccinate has been researched along with anandamide in 2 studies
Studies (delta9-tetrahydrocannabinol hemisuccinate) | Trials (delta9-tetrahydrocannabinol hemisuccinate) | Recent Studies (post-2010) (delta9-tetrahydrocannabinol hemisuccinate) | Studies (anandamide) | Trials (anandamide) | Recent Studies (post-2010) (anandamide) |
---|---|---|---|---|---|
14 | 1 | 4 | 2,566 | 29 | 957 |
Protein | Taxonomy | delta9-tetrahydrocannabinol hemisuccinate (IC50) | anandamide (IC50) |
---|---|---|---|
Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 3.75 | |
Potassium channel subfamily K member 3 | Homo sapiens (human) | 3 | |
Potassium channel subfamily K member 2 | Bos taurus (cattle) | 1 | |
Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 4.78 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berrendero, F; Bisogno, T; Cavaliere, P; Cebeira, M; Di Marzo, V; Fernández-Ruiz, JJ; González, S; Ramos, JA; Romero, J | 1 |
Ambrosio, E; Arévalo, C; Cascio, MG; Di Marzo, V; Fernández-Ruiz, J; González, S; Hernández, M; Nicanor, C; Ramos, JA | 1 |
2 other study(ies) available for delta9-tetrahydrocannabinol hemisuccinate and anandamide
Article | Year |
---|---|
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Topics: Animals; Arachidonic Acids; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Down-Regulation; Dronabinol; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Limbic System; Male; Marijuana Abuse; Morpholines; Naphthalenes; Phosphatidylethanolamines; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Sulfur Radioisotopes; Tritium | 2000 |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Brain; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Corticosterone; Dronabinol; Drug Administration Schedule; Drug Tolerance; Endocannabinoids; Glycerides; Male; Paraventricular Hypothalamic Nucleus; Piperidines; Polyunsaturated Alkamides; Prolactin; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Corticotropin-Releasing Hormone; Rimonabant; RNA, Messenger; Substance Withdrawal Syndrome | 2004 |